Furthermore, we pretreated BMDMs with the Nlrp3 inhibitor (MCC950) and Caspase-1 inhibitor (Z-YVAD-FMK) prior to the infection with SS2, and we observed the expected significant inhibitions to the IL-1β release and cytotoxicity (Figures 5A,B). The gene discussed is CASP1; the disease is infection.